Kirsten Lund-jurgensen, Ph.d.
Executive Vice President and President, Pfizer Glo
external supply network.
United States of America
Kirsten's pharmaceutical industry career spans 30 years, the last 17 with Pfizer, after joining the company from SmithKline Beecham in 1999 as vice president, global supply chain management, Pharmaceuticals. At SmithKline Beecham (Germany, Australia and the U.S.), Kirsten held several operational and functional roles, including site leader of consumer and pharmaceutical plants; vice president, global strategic planning; and vice president, contractor management, Europe. Kirsten was named vice president, supply chain management for all Pfizer global businesses in 2000. She then led the Patented Products Operating Unit (Manufacturing Sites in Europe and Singapore) 2008-2009, and the Primary Care and Oncology, Operating Unit (Manufacturing Sites in Europe, Singapore, Canada) 2009-2012. Kirsten was named vice president, Product Portfolio Management for Primary Care, Established Products and Oncology in 2012. Kirsten was appointed as product portfolio management lead and PGS lead for Vaccines, Oncology, and Consumer in 2014 and subsequently vice president, Innovative Health Product Portfolio Management and Consumer Operations.
Kirsten is a pharmacist from Kiel University in Germany and holds a Ph.D. in Pharmaceutical Biology from Freiburg University in Germany.